Dr. Kamradt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Abbvie Clinical Pharmacology Research Unit
480 South US 45
Grayslake, IL 60030Phone+1 847-935-4421Fax+1 847-935-4402- Is this information wrong?
Education & Training
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Family Medicine, 1987 - 1990
Rush Medical College of Rush University Medical CenterClass of 1987
Certifications & Licensure
IA State Medical License 2021 - 2025
IL State Medical License 1987 - 2023
AZ State Medical License 2004 - 2016
Clinical Trials
- Evaluation of a Nutritional Product for People With Type 2 Diabetes Start of enrollment: 2013 May 01
- Trial of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 7 citationsAssessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor AntagonistAkshanth R. Polepally, Juki Ng, Ahmed Salem, Matthew B. Dufek, Apurvasena Parikh, David Carter, Kent Kamradt, Nael M. Mostafa, Mohamad Shebley> ;Journal of Clinical Pharmacology. 2020 Dec 1
- 3 citationsT vector velocity: A new ECG biomarker for identifying drug effects on cardiac ventricular repolarization.Werner Bystricky, Christoph Maier, Gary Gintant, Dennis Bergau, Kent Kamradt, Patrick Welsh, David Carter> ;Plos One. 2019 Jul 8
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
